EMERGENT BIOSOLUTIONS INC. (EBS) Revenue 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$742.9MFY2025 · since FY2016: $488.8M → $742.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $742.9M | -28.8% |
| FY2024 | $1.0B | -0.5% |
| FY2023 | $1.0B | -6.1% |
| FY2022 | $1.1B | -37.0% |
| FY2021 | $1.8B | +14.0% |
| FY2020 | $1.6B | +40.6% |
| FY2019 | $1.1B | +41.4% |
| FY2018 | $782.4M | +39.5% |
| FY2017 | $560.9M | +14.8% |
| FY2016 | $488.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice